https://pittplusme.org/study/1241
HCC 18-023 (EA8153)
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Have you been diagnosed with prostate cancer that has spread? Have you already undergone treatment with hormone therapy and docetaxel (chemo drug)? If so, you may be eligible to participate in a study to help researchers test any good or bad effects of using the chemotherapy drug cabazitaxel (Jevtana) combined with standard of care treatment compared to people on standard of care treatment alone.
IRB: EA8153
- EA8153, Cabazitaxel with Abiraterone versus Abiraterone alone Randomized Trial for Extensive Disease following Docetaxel: the CHAARTED2 Trial
AGE:
18 and up
SEX ASSIGNED AT BIRTH:
Male
DURATION:
Up to 5 years
LOCATION:
UPMC Hillman Cancer Centers
COMPENSATION:
NONE
SHARE STUDY
